Fundz

Ocugen Appoints Dr. Huma Qamar as Chief Medical Officer (CMO)

PUBLIC · OCGNMar 18, 2024

Position

Chief Medical Officer

Company

Ocugen

Huma Qamar
MalvernBiotechnologyHealthcareHealth CareTherapeutics

Description

Ocugen, Inc. announced the appointment of Dr. Huma Qamar as Chief Medical Officer (CMO)

Quick answer

Ocugen Appoints Dr. Huma Qamar as Chief Medical Officer (CMO) (March 18, 2024). Ocugen is based in Malvern, Pennsylvania, United States.

Who is the new Chief Medical Officer at Ocugen?
Ocugen named Huma Qamar Chief Medical Officer, announced March 18, 2024.
What did Ocugen announce on March 18, 2024?
Ocugen, Inc. announced the appointment of Dr. Huma Qamar as Chief Medical Officer (CMO)
What does Ocugen do?
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe.
Where is Ocugen based?
Ocugen is based in Malvern, Pennsylvania, United States.
Which similar companies made leadership changes around the same time?
Galectin (March 12, 2024), Madrigal Pharmaceuticals (March 11, 2024), Nuvation Bio (March 28, 2024) and Elevation Oncology (March 4, 2024) also announced leadership changes within 45 days of Ocugen.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Ocugen, and when

A new leader at Ocugen brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Ocugen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ocugen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ocugen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ocugen

Location

11 Great Valley Parkway

Malvern, Pennsylvania, United States

About

Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patients’ lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ocugen changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Emily
Senior decision-maker at this company
••••••••@••••••••

See Emily's verified email →

Mahvish
Senior decision-maker at this company
••••••••@••••••••

See Mahvish's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Ocugen's next move

Learn about Strategic plan

Ocugen changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.